Inactive Instrument

Highlights DIUL GROUP

Equities

DNL

GB00BDB6Q760

Highlights

Unlock all the news: Be the first to know and act before the market!

Diurnal Ltd. Presents Phase 3 Extension Study Data for Modified-Release Hydrocortisone in Patients with Congenital Adrenal Hyperplasia at ENDO 2023	23-06-15	CI
Diurnal Shares Delisted After Neurocrine Biosciences Takeover	22-11-02	MT
Diurnal's Takeover Scheme By US-based Neurocrine Biosciences Becomes Effective	22-11-01	MT
Neurocrine Biosciences, Inc. completed the acquisition of Diurnal Group plc from Diurnal Directors, IP Group Plc, Polar Capital Holdings plc, Development Bank of Wales Plc, Amati Global Investors Ltd. and other shareholders.	22-10-31	CI
TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility	22-10-28	AN
Neurocrine's Acquisition of Diurnal Secures Court Approval	22-10-28	MT
TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO	22-10-21	AN
Diurnal's Shareholders Approve Takeover Bid by Neurocrine	22-10-21	MT
Diurnal Group Wins Recommendation for Rare Genetic Disorder Drug in Wales	22-10-07	MT
Diurnal Group plc Announces AWMSG Recommends Efmody for CAH within NHS Wales	22-10-07	CI
Diurnal Group plc Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-14	CI
Diurnal Group plc Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-14	CI
Supermarkets Forecast to Relatively Outperform Retail Sector	22-08-30	DJ
FTSE 100 Led Higher by Banks, Energy Stocks	22-08-30	DJ
Sterling Struggles Continue as Gas Crisis, Structural Issues Weigh	22-08-30	DJ
Diurnal Group Accepts $57 Million Takeover Offer From Neurocrine Biosciences	22-08-30	MT
Diurnal Group plc announces First Patient Dosed in Pivotal Phase 3 Connect Clinical Trial for Us and Japanese Markets	22-06-01	CI
Diurnal Group plc Announces Presentation At European Congress of Endocrinology	22-05-23	CI
Diurnal Extends Swiss Distribution Deal With EffRx to Include Rare Disease Drug Efmody	22-04-25	MT
Diurnal Group plc Extends Its Distribution and Marketing Agreement with Effrx Pharmaceuticals	22-04-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DIUL GROUP

Equities

DNL

GB00BDB6Q760

Highlights

Filters